scholarly journals TCT-550 Comparative Clinical Outcomes with the Initial Use of Impella CP versus Impella 5.0 Devices in Patients with Severe Cardiogenic Shock

2017 ◽  
Vol 70 (18) ◽  
pp. B227-B228
Author(s):  
Rikin Tank ◽  
Richard Cheng ◽  
Danny Ramzy ◽  
Fardad Esmailian ◽  
Jon Kobashigawa ◽  
...  
2018 ◽  
Vol 72 (13) ◽  
pp. B301
Author(s):  
Charlene Rohm ◽  
Marsha Kadner ◽  
Michael Leitson ◽  
Bogdan Gadidov ◽  
Jessica Rudd ◽  
...  

2021 ◽  
Vol 77 (18) ◽  
pp. 2712
Author(s):  
Manjari R. Regmi ◽  
Mohsin Salih ◽  
Mohammad Al-Akchar ◽  
Mukul Bhattarai ◽  
Christopher Lawrance ◽  
...  

Heart & Lung ◽  
2020 ◽  
Vol 49 (6) ◽  
pp. 716-723
Author(s):  
Omar Chehab ◽  
Rami Z. Morsi ◽  
Amjad Kanj ◽  
Rayan Jo Rachwan ◽  
Mohit Pahuja ◽  
...  

2018 ◽  
Vol 19 (4) ◽  
pp. 351-353
Author(s):  
E Forbat ◽  
MJ Rouhani ◽  
C Pavitt ◽  
S Patel ◽  
R Handslip ◽  
...  

Background Leptospirosis is a rare infectious illness caused by the Spirochaete Leptospira. It has a wide-varying spectrum of presentation. We present a rare case of severe cardiogenic shock secondary to leptospirosis, in the absence of its common clinical features. Case presentation A 36-year-old woman presented to our unit with severe cardiogenic shock and subsequent multi-organ failure. Her clinical course was characterised by ongoing pyrexia of unknown origin with concurrent cardiac failure. She was initially managed with broad-spectrum antibiotics and inotropes. Percutaneous cardiac biopsy excluded major causes of myocarditis. On day 21 after presentation, she was found to be IgM-positive for leptospirosis. Conclusions This is a rare case of severe cardiogenic shock secondary to leptospirosis infection. The case also highlights the importance of obtaining a thorough social history when assessing a patient with an unusual presentation, as clues can often be missed.


Sign in / Sign up

Export Citation Format

Share Document